Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06110156 · ClinicalTrials.gov registry record · NA

Population Health Approach to Optimizing Medications in Older Adults

A NA study, sponsored by Cedars-Sinai Medical Center.

Active
Registry status
NA
Development phase
100
Enrollment target

NCT06110156: Active NA study, sponsored by Cedars-Sinai Medical Center.

NCT06110156 is a NA study that is active but no longer recruiting, run by Cedars-Sinai Medical Center. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06110156, a NA study, is active but no longer recruiting, sponsored by Cedars-Sinai Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

This randomized controlled pragmatic pilot study examines the feasibility and acceptability of a population health-based deprescribing intervention that leverages a polypharmacy risk prediction model. It includes four arms (2 intervention and 2 control arms) and uses a parallel arm study design.

Primary Outcome

Number of all-cause inpatient visits (including observation visits) 12 months after enrollment.

Interventions

  • BEHAVIORAL Patient-tailored deprescribing assessment and intervention

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-05-19
Est. Completion 2026-12-01
Phase NA
Cedars-Sinai Medical Center

339 total trials

What the registry record for NCT06110156 still lists

NCT06110156 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which Patient-tailored deprescribing assessment and intervention is the first listed.

NCT06110156 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06110156 about?

NCT06110156 is a clinical study titled "Population Health Approach to Optimizing Medications in Older Adults". This randomized controlled pragmatic pilot study examines the feasibility and acceptability of a population health-based deprescribing intervention that leverages a polypharmacy risk prediction model. It includes four arms (2 intervention and 2 control arms) and uses a parallel arm study design.

What is the current status of trial NCT06110156?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-05-19. Estimated completion is 2026-12-01.

What interventions are being tested in trial NCT06110156?

The interventions under investigation include: Patient-tailored deprescribing assessment and intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06110156?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06110156's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06110156, the US trial registry maintained by the National Library of Medicine. NCT06110156 (mid enrollment · none site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.